neffy, epinephrine nasal spray, Demonstrates a Positive Efficacy and Safety Profile for the Treatment of Allergic Reactions in Pediatric Patients at-Risk of Anaphylaxis: Phase 3 Study Results

被引：0
|
作者：
Ebisawa, Motohiro [1 ]
Lowenthal, Richard [2 ]
Tanimoto, Sarina [3 ]
Takahashi, Kento [4 ]
Takahashi, Kyohei Kyohei [4 ]
Yanagida, Noriyuki [4 ]
Sato, Sakura [4 ]
机构：
[1] Sagamihara Natl Hosp, Sagamihara, Japan
[2] ARS Pharmaceut, San Diego, CA USA
[3] ARS Pharmaceut Inc, San Diego, CA USA
[4] NHO Sagamihara Natl Hosp, Sagamihara, Japan
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2024年 / 153卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
L33
引用
收藏
页码：AB371 / AB371
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of adalimumab versus methotrexate treatment in pediatric patients with severe chronic plaque psoriasis: Results from the 16-Week randomized, double-blind period of a phase 3 study
    Papp, Kim
    Thaci, Diamant
    Marcoux, Danielle
    Weibel, Lisa
    Unnebrink, Kristina
    Williams, David A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S15 - S15
  • [32] Examination of the Inter-Seizure-Cluster Interval Over Time in Pediatric Patients in a Phase 3, Long-Term Open-Label, Repeat-Dose Safety Study of Diazepam Nasal Spray for the Treatment of Seizure Clusters
    Misra, S.
    Sperling, M.
    Rao, V.
    Peters, J.
    ANNALS OF NEUROLOGY, 2022, 92 : S73 - S73
  • [33] Adis summary of research: Efficacy and safety of esketamine nasal spray in patients with treatment-resistant depression who completed a second induction period: analysis of the ongoing SUSTAIN-3 study
    Hoy, Sheridan M.
    DRUGS & THERAPY PERSPECTIVES, 2024, 40 (10) : 383 - 384
  • [34] Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study
    Hargrave, Darren R.
    Bouffet, Eric
    Tabori, Uri
    Broniscer, Alberto
    Cohen, Kenneth J.
    Hansford, Jordan R.
    Geoerger, Birgit
    Hingorani, Pooja
    Dunkel, Ira J.
    Russo, Mark W.
    Tseng, Lillian
    Dasgupta, Kohinoor
    Gasal, Eduard
    Whitlock, James A.
    Kieran, Mark W.
    CLINICAL CANCER RESEARCH, 2019, 25 (24) : 7303 - 7311
  • [35] Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study
    Takeshima, Takao
    Sakai, Fumihiko
    Hirata, Koichi
    Imai, Noboru
    Matsumori, Yasuhiko
    Yoshida, Ryuji
    Peng, Cheng
    Cheng, Sunfa
    Mikol, Daniel D.
    HEADACHE, 2021, 61 (06): : 927 - 935
  • [36] A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results
    Magnolo, Nina
    Kingo, Kulli
    Laquer, Vivian
    Browning, John
    Reich, Adam
    Szepietowski, Jacek C.
    Keefe, Deborah
    Mazur, Rafal
    Ghelani, Prayashi
    Forrer, Pascal
    Wraith, LindaAnn
    Patekar, Manmath
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (01) : 122 - 130
  • [37] Efficacy and Safety of Lanadelumab in pediatric Patients with hereditary Angioedema aged 2 to < 12 Years: Results of the open-label, multi-centric Phase 3 SPRING Study
    Kappek, M.
    Maurer, M.
    Lumry, W. R.
    Li, H. H.
    Aygoeren-Pursun, E.
    Busse, P.
    Jacobs, J.
    Nurse, C.
    ALLERGOLOGIE, 2023, 46 (08) : 560 - 560
  • [38] Efficacy and safety of STS101 DHE nasal powder for the acute treatment of migraine: Results from the Phase 3 double-blind, randomized, placebo-controlled SUMMIT study
    Lipton, R.
    Tepper, S.
    Albrecht, D.
    HEADACHE, 2023, 63 : 112 - 113
  • [39] Phase 2 Expansion Study of Oral Rigosertib Combined With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Efficacy and Safety Results in HMA Treatment-Naive and Relapsed/Refractory Patients
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (02) : 8 - 9
  • [40] Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2)
    Wajs, Ewa
    Aluisio, Leah
    Holder, Richard
    Daly, Ella J.
    Lane, Rosanne
    Lim, Pilar
    George, Joyce E.
    Morrison, Randall L.
    Sanacora, Gerard
    Young, Allan H.
    Kasper, Siegfried
    Sulaiman, Ahmad Hatim
    Li, Cheng-Ta
    Paik, Jong-Woo
    Manji, Husseini
    Hough, David
    Grunfeld, Jennifer
    Jeon, Hong Jin
    Wilkinson, Samuel T.
    Drevets, Wayne C.
    Singh, Jaskaran B.
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (03)
12345